{"filing":{"accession_number":"0001193125-26-303344","cik":"0002137777","ticker":null,"company_name":"Research Alliance Corp IV","form":"8-K","filing_date":"2026-07-14","report_date":null,"primary_document":"d138133d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2137777/000119312526303344/d138133d8k.htm"},"events":[{"id":17917,"run_id":16074,"accession_number":"0001193125-26-303344","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"Research Alliance Corp IV entered into multiple material definitive agreements in connection with its initial public offering, including an Underwriting Agreement, Investment Management Trust Agreement, Registration and Shareholder Rights Agreement, and Private Placement Shares Purchase Agreement. These agreements establish the company's capitalization and governance framework for pursuing a business combination.","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16571,"accession_number":"0001193125-26-303344","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"This Item 1.01 discloses entry into multiple material definitive agreements in connection with Research Alliance Corp IV's initial public offering, including an Underwriting Agreement, Investment Management Trust Agreement, Registration and Shareholder Rights Agreement, and Private Placement Shares Purchase Agreement. While technically an IPO rather than a traditional M\u0026A transaction, the Item 1.01 classification and the nature of these agreements—particularly the Private Placement Shares Purchase Agreement and the Letter Agreement governing the initial business combination process—constitute a material capital-raising and structural event that would affect a reasonable investor's assessment of the registrant. The $75 million IPO and related agreements establish the company's capitalization and governance framework for pursuing a business combination.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":17918,"run_id":16074,"accession_number":"0001193125-26-303344","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Research Alliance Corp IV completed an unregistered private placement of 275,000 Class A ordinary shares to the Sponsor at $10.00 per share, generating $2.75 million in proceeds pursuant to Section 4(a)(2) of the Securities Act, simultaneously with the IPO closing.","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16572,"accession_number":"0001193125-26-303344","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses a private placement of 275,000 Class A ordinary shares to the Sponsor at $10.00 per share, generating $2.75 million in proceeds. The shares were issued pursuant to Section 4(a)(2) of the Securities Act (unregistered), and the transaction occurred simultaneously with the IPO closing. This is a classic dilutive issuance—an unregistered equity sale that increases share count and dilutes existing shareholders, particularly material in the SPAC context where the Sponsor's ownership stake is a key investor concern.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":17919,"run_id":16074,"accession_number":"0001193125-26-303344","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Alan Musso and John Maslowski were appointed to the Board of Directors effective July 10, 2026, in connection with the Company's IPO, with concurrent appointments to the Audit, Nominating, and Compensation committees.","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16573,"accession_number":"0001193125-26-303344","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The Item 5.02 disclosure centers on the appointment of Alan Musso and John Maslowski to the Board of Directors effective July 10, 2026, in connection with the Company's IPO, along with their concurrent appointments to three board committees (Audit, Nominating, and Compensation). While the section also mentions compensatory arrangements (30,000 Class B shares transferred to each director), the principal disclosed action is the appointment of these two individuals to the Board and committee roles, making exec_appointment the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":17920,"run_id":16074,"accession_number":"0001193125-26-303344","anchor_item_number":"8.01","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.65,"summary":"Research Alliance Corp IV announced the pricing and closing of a $75 million initial public offering, establishing the company's public capitalization and status as a special purpose acquisition company (SPAC).","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16575,"accession_number":"0001193125-26-303344","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing announces the pricing and imminent closing of a $75 million initial public offering (IPO) by Research Alliance Corp IV, a special purpose acquisition company (SPAC). While IPO pricing is a material capital-raising event affecting the registrant's capitalization and public status, it does not fit neatly into the provided taxonomy. The event is clearly material and financial in nature, but the taxonomy lacks a dedicated \"IPO\" or \"capital_raising\" category. The closest fit would be `dilutive_issuance` (equity issuance), but that category is typically reserved for private placements and unregistered sales, not registered public offerings. Accordingly, `other_material` is the most appropriate classification, reflecting that the domain (financial/capital) is clear but no specific type in the taxonomy applies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":17921,"run_id":16074,"accession_number":"0001193125-26-303344","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"summary":"Research Alliance Corp IV adopted an Amended and Restated Memorandum and Articles of Association on July 10, 2026, in connection with IPO completion.","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16574,"accession_number":"0001193125-26-303344","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"Item 5.03 discloses adoption of Amended and Restated Memorandum and Articles of Association on July 10, 2026, in connection with the IPO. This is a routine governance document amendment required for IPO completion. While the IPO itself is material, the Item 5.03 disclosure is a standard administrative filing of the governing documents, not a material event in its own right. The supplemental press release confirms the IPO pricing and closing, but Item 5.03 specifically addresses only the bylaw/charter amendment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16571,"accession_number":"0001193125-26-303344","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"This Item 1.01 discloses entry into multiple material definitive agreements in connection with Research Alliance Corp IV's initial public offering, including an Underwriting Agreement, Investment Management Trust Agreement, Registration and Shareholder Rights Agreement, and Private Placement Shares Purchase Agreement. While technically an IPO rather than a traditional M\u0026A transaction, the Item 1.01 classification and the nature of these agreements—particularly the Private Placement Shares Purchase Agreement and the Letter Agreement governing the initial business combination process—constitute a material capital-raising and structural event that would affect a reasonable investor's assessment of the registrant. The $75 million IPO and related agreements establish the company's capitalization and governance framework for pursuing a business combination.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14"},{"id":16572,"accession_number":"0001193125-26-303344","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses a private placement of 275,000 Class A ordinary shares to the Sponsor at $10.00 per share, generating $2.75 million in proceeds. The shares were issued pursuant to Section 4(a)(2) of the Securities Act (unregistered), and the transaction occurred simultaneously with the IPO closing. This is a classic dilutive issuance—an unregistered equity sale that increases share count and dilutes existing shareholders, particularly material in the SPAC context where the Sponsor's ownership stake is a key investor concern.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14"},{"id":16573,"accession_number":"0001193125-26-303344","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The Item 5.02 disclosure centers on the appointment of Alan Musso and John Maslowski to the Board of Directors effective July 10, 2026, in connection with the Company's IPO, along with their concurrent appointments to three board committees (Audit, Nominating, and Compensation). While the section also mentions compensatory arrangements (30,000 Class B shares transferred to each director), the principal disclosed action is the appointment of these two individuals to the Board and committee roles, making exec_appointment the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14"},{"id":16574,"accession_number":"0001193125-26-303344","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"Item 5.03 discloses adoption of Amended and Restated Memorandum and Articles of Association on July 10, 2026, in connection with the IPO. This is a routine governance document amendment required for IPO completion. While the IPO itself is material, the Item 5.03 disclosure is a standard administrative filing of the governing documents, not a material event in its own right. The supplemental press release confirms the IPO pricing and closing, but Item 5.03 specifically addresses only the bylaw/charter amendment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14"},{"id":16575,"accession_number":"0001193125-26-303344","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing announces the pricing and imminent closing of a $75 million initial public offering (IPO) by Research Alliance Corp IV, a special purpose acquisition company (SPAC). While IPO pricing is a material capital-raising event affecting the registrant's capitalization and public status, it does not fit neatly into the provided taxonomy. The event is clearly material and financial in nature, but the taxonomy lacks a dedicated \"IPO\" or \"capital_raising\" category. The closest fit would be `dilutive_issuance` (equity issuance), but that category is typically reserved for private placements and unregistered sales, not registered public offerings. Accordingly, `other_material` is the most appropriate classification, reflecting that the domain (financial/capital) is clear but no specific type in the taxonomy applies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:59:49.031838+00:00","company_name":"Research Alliance Corp IV","ticker":null,"filing_date":"2026-07-14"}]}